Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Jubilant Pharma LimitedJubilant Pharma Limited
VS
Astellas PharmaAstellas Pharma
Jubilant Pharma Limited

Jubilant Pharma Limited

790 Township Line Rd, Yardley, 19067, US

Last Update: 16/02/2026

View Profile
Between 750 and 799
https://jubilantpharma.com
753/1000Fair

Jubilant Pharma Limited is a global integrated pharmaceutical company offering a wide range of products and services to our customers across geographies. We organize our business into two segments, namely, Specialty Pharmaceuticals, comprising Radiopharmaceuticals (in...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:174
Subsidiaries:13
12-month incidents
0
Known data breaches
0
Attack type number
0
Astellas Pharma

Astellas Pharma

2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo, JP, 103-8411

Last Update: 05/04/2026

View Profile
Between 800 and 849
http://www.astellas.com/
802/1000Good

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and develo...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:12,110
Subsidiaries:1
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Jubilant Pharma Limited

Jubilant Pharma Limited

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Astellas Pharma

Astellas Pharma

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Jubilant Pharma Limited in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Astellas Pharma in 2026.

Incidents

Incident History - Jubilant Pharma Limited (X = Date, Y = Severity)

Jubilant Pharma Limited cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Astellas Pharma (X = Date, Y = Severity)

Astellas Pharma cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Jubilant Pharma Limited

Jubilant Pharma Limited

Incidents
No explicit notable incidents reported.
Astellas Pharma

Astellas Pharma

Incidents
No explicit notable incidents reported.

FAQ

Between Jubilant Pharma Limited company and Astellas Pharma company, which one has the best AI Cybersecurity Score ?
Between Jubilant Pharma Limited company and Astellas Pharma company, which one has experienced more cyber incidents in the past ?
Between Jubilant Pharma Limited company and Astellas Pharma company, which one has experienced more cyber incidents this year ?
Between Jubilant Pharma Limited company and Astellas Pharma company, which one has experienced at least one ransomware attack ?
Between Jubilant Pharma Limited company and Astellas Pharma company, which one has experienced at least one data breach ?
Between Jubilant Pharma Limited company and Astellas Pharma company, which one has experienced at least one targeted cyberattack ?
Between Jubilant Pharma Limited company and Astellas Pharma company, which one has experienced at least one vulnerability ?
Between Jubilant Pharma Limited company and Astellas Pharma company, which one holds the most compliance certifications ?
Between Jubilant Pharma Limited company and Astellas Pharma company, which one holds the fewest compliance certifications ?
Between Jubilant Pharma Limited company and Astellas Pharma company, which one has the most subsidiaries ?
Between Jubilant Pharma Limited company and Astellas Pharma company, which one has the largest number of employees ?
Between Jubilant Pharma Limited and Astellas Pharma, which company holds both SOC 2 Type 1 certifications ?
Between Jubilant Pharma Limited and Astellas Pharma, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Jubilant Pharma Limited or Astellas Pharma ?
Which company is PCI DSS compliant - Jubilant Pharma Limited or Astellas Pharma ?
Between Jubilant Pharma Limited and Astellas Pharma, which company complies with HIPAA regulations for healthcare data ?
Between Jubilant Pharma Limited and Astellas Pharma, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-82592
SUMMARY

A vulnerability was detected in D-Link DIR-825M 1.1.8. This affects the function sub_46725C of the file /boafrm/formDiskFormat of the component Disk Formatting Handler Endpoint. The manipulation of the argument partition results in stack-based buffer overflow. The attack can be executed remotely. The exploit is now public and may be used.

PUBLISHED
Date2026-08-30
UPDATED
Date2026-08-30
RISK INFORMATION (Score: 9.9)
CVSS2
Base Score: 9.0
Complexity: LOW
AV:N/AC:L/Au:S/C:C/I:C/A:C
CVSS3
Base Score: 9.9
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
CVSS4
Base Score: 8.6
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
6
EXPLOITABILITY
3.1
CVE-2026-82591
SUMMARY

A security vulnerability has been detected in Open Asset Import Library Assimp up to 6.0.2. The impacted element is the function MD5Importer::MakeDataUnique of the file code/AssetLib/MD5/MD5Loader.cpp. The manipulation of the argument iNewIndex leads to heap-based buffer overflow. The attack can only be performed from a local environment. The identifier of the patch is bf9dabb617c46e5133dac65cca6bff177917afcb. Applying a patch is the recommended action to fix this issue.

PUBLISHED
Date2026-08-30
UPDATED
Date2026-08-30
RISK INFORMATION (Score: 5.3)
CVSS2
Base Score: 4.3
Complexity: LOW
AV:L/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 5.3
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 4.8
Complexity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
1.8
CVE-2026-82590
SUMMARY

A weakness has been identified in Open5GS up to 2.7.7. The affected element is the function smf_nudm_sdm_handle_get of the file src/smf/nudm-handler.c of the component SMF. Executing a manipulation of the argument preemptCap can lead to reachable assertion. The attack may be launched remotely. Upgrading to version 2.8.0 is sufficient to fix this issue. This patch is called 4554405f29bffd7562abedbee63484825bd90cd5. You should upgrade the affected component.

PUBLISHED
Date2026-08-30
UPDATED
Date2026-08-30
RISK INFORMATION (Score: 4.3)
CVSS2
Base Score: 4.0
Complexity: LOW
AV:N/AC:L/Au:S/C:N/I:N/A:P
CVSS3
Base Score: 4.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
2.8
CVE-2026-82589
SUMMARY

A security flaw has been discovered in Open5GS up to 2.7.7. Impacted is the function amf_namf_comm_handle_n1_n2_message_transfer of the file src/amf/namf-handler.c of the component N1-N2 Message Handler. Performing a manipulation of the argument N1N2MessageTransferReqData.n2InfoContainer.smInfo.n2InfoContent.ngapIeType results in denial of service. The attack may be initiated remotely. The exploit has been released to the public and may be used for attacks. Upgrading to version 2.8.0 is recommended to address this issue. The patch is named abf8a836564b966b5141110fc25ed413c4f17522. It is advisable to upgrade the affected component.

PUBLISHED
Date2026-08-30
UPDATED
Date2026-08-30
RISK INFORMATION (Score: 4.3)
CVSS2
Base Score: 4.0
Complexity: LOW
AV:N/AC:L/Au:S/C:N/I:N/A:P
CVSS3
Base Score: 4.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
2.8
CVE-2026-82588
SUMMARY

A vulnerability was identified in Open5GS up to 2.7.7. This issue affects some unknown processing of the file src/amf/namf-handler.c of the component Transfer Endpoint. Such manipulation leads to null pointer dereference. The attack can be launched remotely. Upgrading to version 2.8.0 is capable of addressing this issue. The name of the patch is abf8a836564b966b5141110fc25ed413c4f17522. Upgrading the affected component is advised.

PUBLISHED
Date2026-08-30
UPDATED
Date2026-08-30
RISK INFORMATION (Score: 4.3)
CVSS2
Base Score: 4.0
Complexity: LOW
AV:N/AC:L/Au:S/C:N/I:N/A:P
CVSS3
Base Score: 4.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
1.4
EXPLOITABILITY
2.8